[HTML][HTML] Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis

K Whitford, B Liu, J Micallef, JK Yin… - Bulletin of the World …, 2018 - ncbi.nlm.nih.gov
Objective To conduct a systematic review and meta-analysis of the long-term impact of infant
vaccination on the prevalence of hepatitis B virus (HBV) infection at the population level …

Global perspective on hepatitis B virus infections in the era of effective vaccines

C Gomes, RJ Wong, RG Gish - Clinics in liver disease, 2019 - liver.theclinics.com
Hepatitis B virus (HBV) is a leading cause of morbidity and mortality worldwide. 1 Viral
hepatitis deaths have increased globally from 0.89 million to 1.45 million between 1990 and …

Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students …

C Bini, M Grazzini, M Chellini, N Mucci… - Human vaccines & …, 2018 - Taylor & Francis
Universal vaccination programmes against Hepatitis B Virus (HBV) have significantly
reduced the burden of the disease; nevertheless, HBV infection remains a relevant issue for …

Hepatitis B seroprevalence in the pediatric and adolescent population of Florence (Italy): An update 27 years after the implementation of universal vaccination

B Zanella, A Bechini, S Boccalini, G Sartor, E Tiscione… - Vaccines, 2020 - mdpi.com
Background: Hepatitis B still represents a health concern, although safe and effective
vaccines have been available since 1982. Italy introduced a program of universal …

The first 30 years of the universal hepatitis-B vaccination-program in Italy: a health strategy with a relevant and favorable economic-profile

S Boccalini, B Bonito, B Zanella, D Liedl… - International Journal of …, 2022 - mdpi.com
In 1991, Italy was one of the first countries worldwide to introduce a universal hepatitis-B
vaccination for children. Since then, epidemiological data have clearly demonstrated the …

A cohesive E uropean policy for hepatitis B vaccination, are we there yet?

T Lernout, G Hendrickx, A Vorsters… - Clinical Microbiology …, 2014 - Wiley Online Library
Despite the availability of safe and effective hepatitis B virus (HBV) vaccines for more than
30 years, the burden of hepatitis B disease is still substantial. In 1992, the WHO …

A new vaccine escape mutant of hepatitis B virus causes occult infection

Q Ye, S Shang, W Li - Human vaccines & immunotherapeutics, 2015 - Taylor & Francis
There is growing public concern regarding assay sensitivity to HBsAg mutants in clinical
diagnosis and vaccine escape. The aim of this study is to introduce a new HBsAg mutant …

High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students …

M Grazzini, G Arcangeli, N Mucci… - Human vaccines & …, 2020 - Taylor & Francis
Healthcare workers (HCWs) are considered high-risk subjects for Hepatitis B Virus (HBV)
infection due to occupational exposure to blood and body fluids. Vaccination represents the …

Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

EG Giannini, G Pieri, S Labanca, MCP Torres… - Digestive and Liver …, 2022 - Elsevier
Background Comprehensive and contemporary data pertaining large populations of patients
with Primary Biliary Cholangitis (PBC) and hepatocellular carcinoma (HCC) are missing …

Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China

Y Wang, M Shu, J Chen, F Shen, H Ren… - Frontiers in Public …, 2023 - frontiersin.org
Background China has long been with high Hepatitis B Virus (HBV) prevalence in the world.
The HBV prevalence of people aged 1–59 decreased to less than 8% in 2006, and by 2020 …